Daiwa Securities Group Inc. has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of the close of business on September 30, 2026. The filing, submitted by Chief Compliance Officer N Holly Dito on October 29, 2026, details the investment positions held by the firm and its affiliated entities.
The report identifies five affiliated entities that reported holdings during the specified period. These include Daiwa America Strategic Advisors Corp, Daiwa Asset Management Co. Ltd, Daiwa Capital Markets America Inc., Daiwa Next Bank, LTD, and Daiwa Securities Co. Ltd.
The information table accompanying the filing lists a diverse portfolio of common stock and derivative positions. Notable holdings include significant positions in technology and consumer sectors. The portfolio includes shares in Apple Inc., Amazon.com Inc., Alphabet Inc., and Microsoft Corp. The filing also lists positions in healthcare companies such as AbbVie Inc., Amgen Inc., and Eli Lilly and Co.
In addition to common stock, the report includes various derivative instruments, such as call and put options. For example, Daiwa holds call options for AbbVie Inc. and put options for Boeing Co. The filing also includes debt instruments, such as notes and preferred stock, issued by companies like Akamai Technologies Inc. and BioMarin Pharmaceutical Inc.
